Hong Kong University study that covers BioNTech and Sinovac shows two vaccines are not enough against Omicron. Don't produce.
HKU study: Two doses of the vaccine are not effective against the Omicron strain and cannot produce enough antibodies. Research subjects include the BioNTech and Kexon vaccines.